Clinical study of Darvyadi Kwatha in Hyperlipidemia of Sthula Subjects
Phase 2
- Registration Number
- CTRI/2020/08/027145
- Lead Sponsor
- Rohini Ashok Kathale
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
BMI >25 AND UP TO 34.9 WITH Serum total cholesterol 200 mg/dl to 240 mg/dl OR Serum triglyceride 150 mg/dl to 300mg/dl
Exclusion Criteria
Subjects having history of any critical illness.
Patients already taking medicine for Hyperlipidemia.
Subjects not willing for trial.
Dyslipidemia due to consumption of drugs such as Glucocorticoids.
Patients with DM, HTN, Endocrine disorders, cardiac and renal impairment.Pregnant females and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method REDUCTION IN SERUM CHOLESTEROL AND REDUCTION IN SERUM TRIGLYCERIDESTimepoint: IN 40 DAYS
- Secondary Outcome Measures
Name Time Method REDUCTION IN BMI AND STHAULYA LAKSHANATimepoint: IN 40 DAYS